{"id":"https://openalex.org/W1593874097","doi":"https://doi.org/10.4049/jimmunol.1202645","title":"Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy","display_name":"Ofatumumab Is More Efficient than Rituximab in Lysing B Chronic Lymphocytic Leukemia Cells in Whole Blood and in Combination with Chemotherapy","alternate_titles":[],"publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1593874097","doi":"https://doi.org/10.4049/jimmunol.1202645","mag":"1593874097","pmid":"https://pubmed.ncbi.nlm.nih.gov/23225880"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.1202645","doi":"https://doi.org/10.4049/jimmunol.1202645","is_oa":true,"landing_page_url":"https://doi.org/10.4049/jimmunol.1202645","pdf_url":"https://www.jimmunol.org/content/jimmunol/190/1/231.full.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"parent_works":[{"id":"https://openalex.org/W2417824122","display_name":"Six new species of Thalassaphorura (Collembola, Onychiuridae) from southern China, with a key to world species of the genus","relationship":"part"}],"lineage":["https://openalex.org/W1593874097","https://openalex.org/W2417824122"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.jimmunol.org/content/jimmunol/190/1/231.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Luca Bologna","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luca Bologna","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003582463","display_name":"Elisa Gotti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisa Gotti","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064559459","display_name":"Fabio Da Roit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fabio Da Roit","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070777479","display_name":"Tamara Intermesoli","orcid":"https://orcid.org/0000-0001-8067-8257","observed_orcids":["https://orcid.org/0000-0001-8067-8257"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tamara Intermesoli","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055401685","display_name":"Alessandro Rambaldi","orcid":"https://orcid.org/0000-0002-3739-7502","observed_orcids":["https://orcid.org/0000-0002-3739-7502"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alessandro Rambaldi","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035673194","display_name":"Martino Introna","orcid":"https://orcid.org/0000-0001-6216-0892","observed_orcids":["https://orcid.org/0000-0001-6216-0892"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martino Introna","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018208681","display_name":"Jos\u00e9e Golay","orcid":"https://orcid.org/0000-0002-7932-909X","observed_orcids":["https://orcid.org/0000-0002-7932-909X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jos\u00e9e Golay","raw_affiliation_strings":["Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Cellular Therapy \u201cG. Lanzani,\u201d Division of Hematology, Ospedali Riuniti di Bergamo, 24128 Bergamo, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":{"value":3500,"currency":"USD","value_usd":3500},"fwci":10.9249,"has_fulltext":true,"cited_by_count":114,"citation_normalized_percentile":{"value":0.98816305,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"190","issue":"1","first_page":"231","last_page":"239"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":1.0},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":1.0},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9629999995231628},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.8740000128746033},{"id":"https://openalex.org/keywords/complement-mediated-cell-lysis","display_name":"complement-mediated lysis","score":0.734000027179718},{"id":"https://openalex.org/keywords/nk-cell-activation","display_name":"NK cell activation","score":0.7170000076293945},{"id":"https://openalex.org/keywords/cd55","display_name":"CD55","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cd59","display_name":"CD59","score":0.9929999709129333},{"id":"https://openalex.org/keywords/complement-inhibition","display_name":"complement inhibition","score":0.5479999780654907},{"id":"https://openalex.org/keywords/eculizumab","display_name":"eculizumab","score":0.8849999904632568},{"id":"https://openalex.org/keywords/phagocytosis","display_name":"phagocytosis","score":0.9710000157356262},{"id":"https://openalex.org/keywords/mafosfamide","display_name":"mafosfamide","score":0.9300000071525574},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/chemoimmunotherapy","display_name":"chemoimmunotherapy","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.5559999942779541}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.796869158744812},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.7685282826423645},{"id":"https://openalex.org/C18031839","wikidata":"https://www.wikidata.org/wiki/Q5009796","display_name":"CD20","level":3,"score":0.6410515904426575},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.6207064986228943},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.5804073214530945},{"id":"https://openalex.org/C184404459","wikidata":"https://www.wikidata.org/wiki/Q5009828","display_name":"CD59","level":4,"score":0.5275173783302307},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.4965437054634094},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.47179311513900757},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.44433659315109253},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.44401875138282776},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.43792724609375},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4194440543651581},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.39242303371429443},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.38201335072517395},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.34925028681755066},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26918768882751465},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2607775628566742},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2427542805671692},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1447061002254486},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06862634420394897},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.05817294120788574},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003167","descriptor_name":"Complement Activation","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003601","descriptor_name":"Cytotoxicity Tests, Immunologic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D004306","descriptor_name":"Dose-Response Relationship, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D015451","descriptor_name":"Leukemia, Lymphocytic, Chronic, B-Cell","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018951","descriptor_name":"Antigens, CD20","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.4049/jimmunol.1202645","doi":"https://doi.org/10.4049/jimmunol.1202645","is_oa":true,"landing_page_url":"https://doi.org/10.4049/jimmunol.1202645","pdf_url":"https://www.jimmunol.org/content/jimmunol/190/1/231.full.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:23225880","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23225880","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Comparative Study"},{"id":"pmh:oai:zenodo.org:198238","doi":null,"is_oa":true,"landing_page_url":"https://www.openaccessrepository.it/record/198238","pdf_url":null,"source":{"id":"https://openalex.org/S4306402478","display_name":"INFM-OAR (INFN Catania)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210116497","host_organization_name":"Istituto Nazionale di Fisica Nucleare, Sezione di Catania","host_organization_lineage":["https://openalex.org/I4210116497"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.5281/zenodo.198238","doi":"https://doi.org/10.5281/zenodo.198238","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.198238","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Image"}],"best_oa_location":{"id":"doi:10.4049/jimmunol.1202645","doi":"https://doi.org/10.4049/jimmunol.1202645","is_oa":true,"landing_page_url":"https://doi.org/10.4049/jimmunol.1202645","pdf_url":"https://www.jimmunol.org/content/jimmunol/190/1/231.full.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320315319","display_name":"Roche Italia","ror":"https://ror.org/01x544h30"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1593874097.pdf","grobid_xml":"https://content.openalex.org/works/W1593874097.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W33733012","https://openalex.org/W1721657566","https://openalex.org/W1897592311","https://openalex.org/W1942856476","https://openalex.org/W1947298690","https://openalex.org/W1965235365","https://openalex.org/W1967692922","https://openalex.org/W1977422931","https://openalex.org/W1997253468","https://openalex.org/W2006128988","https://openalex.org/W2016973656","https://openalex.org/W2022069273","https://openalex.org/W2024547239","https://openalex.org/W2037044333","https://openalex.org/W2044360617","https://openalex.org/W2045461884","https://openalex.org/W2049353008","https://openalex.org/W2069524809","https://openalex.org/W2069724524","https://openalex.org/W2073019775","https://openalex.org/W2091291743","https://openalex.org/W2102809922","https://openalex.org/W2105158060","https://openalex.org/W2107567250","https://openalex.org/W2116262245","https://openalex.org/W2122725450","https://openalex.org/W2124575836","https://openalex.org/W2125134816","https://openalex.org/W2129041705","https://openalex.org/W2141139539","https://openalex.org/W2143728536","https://openalex.org/W2146682305","https://openalex.org/W2146924887","https://openalex.org/W2147639736","https://openalex.org/W2153255423","https://openalex.org/W2158803162","https://openalex.org/W2159257554","https://openalex.org/W2160690356","https://openalex.org/W2165916281","https://openalex.org/W2168750246"],"related_works":["https://openalex.org/W2132467087","https://openalex.org/W2294390837","https://openalex.org/W2052868810","https://openalex.org/W2565656247","https://openalex.org/W2150249991","https://openalex.org/W2079089580","https://openalex.org/W2129358485","https://openalex.org/W11737159","https://openalex.org/W2328723989","https://openalex.org/W2145402798"],"abstract_inverted_index":{"Ofatumumab":[0],"(OFA)":[1],"is":[2,23],"a":[3,77,105],"human":[4,165],"anti-CD20":[5,253],"Ab":[6,102],"approved":[7],"for":[8,158],"treatment":[9,183],"of":[10,19,89,107,176,235],"fludarabine-refractory":[11],"B":[12],"chronic":[13],"lymphocytic":[14],"leukemia":[15],"(B-CLL).":[16],"The":[17],"efficacy":[18],"different":[20],"immunotherapeutic":[21],"strategies":[22,248],"best":[24],"investigated":[25],"in":[26,46,51,65,111,160,173,195,214,218,241],"conditions":[27,220,243],"that":[28,189],"are":[29,193],"as":[30,32,95],"physiologic":[31,219],"possible.":[33],"We":[34],"have":[35],"therefore":[36],"compared":[37,84,208,230],"the":[38,174,221,233],"activity":[39,88,203],"OFA":[40,59,90,149,207,228],"and":[41,70,104,133,186,200,217,239,244],"rituximab":[42],"(RTX),":[43],"alone":[44,229],"or":[45,167,178],"combination":[47],"with":[48,71,76,85,142,184,206,209,231],"chemotherapeutic":[49],"agents":[50],"unmanipulated":[52],"whole":[53,66,112,179,197],"blood":[54,67,198],"assays,":[55],"using":[56,163,249],"flow":[57],"cytometry.":[58],"(10-100":[60],"\u03bcg/ml)":[61],"lysed":[62],"B-CLL":[63,196,215],"targets":[64],"more":[68],"efficiently":[69],"faster":[72],"kinetics":[73],"than":[74],"RTX,":[75,232],"mean":[78],"56%":[79],"lysis":[80,123,139],"at":[81],"24":[82],"h":[83],"16%.":[86],"This":[87],"was":[91,118,171],"fully":[92],"complement":[93,135,223],"dependent,":[94],"shown":[96],"by":[97,100,120,130,227],">99%":[98],"inhibition":[99],"anti-C5":[101],"eculizumab":[103],"lack":[106,234],"NK":[108,115,236],"cell":[109,116,237],"activation":[110,117],"blood.":[113,180],"OFA-mediated":[114,122,138],"blocked":[119],"complement.":[121],"could":[124],"be":[125],"increased":[126],"an":[127],"additional":[128],"15%":[129],"blocking":[131],"CD55":[132],"CD59":[134],"inhibitors.":[136],"Interestingly,":[137],"correlated":[140],"significantly":[141],"CD20":[143],"expression":[144],"levels":[145],"(r(2)":[146],"=":[147],"0.79).":[148],"showed":[150,188],"overlapping":[151],"dose":[152],"response":[153],"curves":[154],"similar":[155],"to":[156],"those":[157],"RTX":[159],"phagocytosis":[161,170,240],"assays":[162,199],"either":[164],"macrophages":[166],"neutrophils.":[168],"However,":[169],"inhibited":[172],"presence":[175],"serum":[177],"Finally,":[181],"combined":[182,205],"mafosfamide":[185],"fludarabine":[187],"these":[190,242],"therapeutic":[191],"drugs":[192],"synergistic":[194],"show":[201],"superior":[202,222],"when":[204],"RTX.":[210],"These":[211],"results":[212],"confirm":[213],"samples":[216],"mediated":[224],"cytotoxicity":[225],"induced":[226],"activation,":[238],"suggest":[245],"effective":[246],"chemoimmunotherapy":[247],"this":[250],"new":[251],"generation":[252],"Ab.":[254]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1593874097","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":22},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":14}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
